Page last updated: 2024-09-03

24-hydroxycholesterol and Cognition Disorders

24-hydroxycholesterol has been researched along with Cognition Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Donato, S; Leoni, V; Long, JD; Mills, JA; Paulsen, JS1
Andreasen, N; Besga, A; Björkhem, I; Julin, P; Kivipelto, M; Leoni, V; Oksengård, AR; Soininen, H; Solomon, A; Svensson, L; Wahlund, LO; Winblad, B1
Li, C; Liao, W; Liu, X; Xu, H; Xu, N; Yu, C; Zhao, S1
Becker, JT; Evans, RW; Hughes, TM; Kuller, LH; Lopez, OL; Rosano, C; Sutton-Tyrrell, K1
Capurso, A; Capurso, C; Capurso, SA; Colacicco, AM; D'Introno, A; Panza, F; Pellicani, V; Pietrarossa, G; Santamato, V; Solfrizzi, V; Todarello, O1
Björkhem, I; Kivipelto, M; Leoni, V; Shafaati, M; Solomon, A1

Reviews

1 review(s) available for 24-hydroxycholesterol and Cognition Disorders

ArticleYear
Circulating biomarkers of cognitive decline and dementia.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 364, Issue:1-2

    Topics: Amyloid beta-Peptides; Biomarkers; Cholesterol; Cholesterol, HDL; Cognition Disorders; Dementia; Humans; Hydroxycholesterols; Peptide Fragments

2006

Other Studies

5 other study(ies) available for 24-hydroxycholesterol and Cognition Disorders

ArticleYear
Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.
    Neurobiology of disease, 2013, Volume: 55

    Topics: Adult; Cognition Disorders; Disability Evaluation; Disease Progression; Female; Gas Chromatography-Mass Spectrometry; Humans; Huntington Disease; Hydroxycholesterols; International Cooperation; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Statistics as Topic; Verbal Learning

2013
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Neuroscience letters, 2009, Oct-02, Volume: 462, Issue:1

    Topics: Age Factors; Aged; Alzheimer Disease; Apolipoproteins E; Brain; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cognition Disorders; Female; Genotype; Humans; Hydroxycholesterols; Lanosterol; Male; Middle Aged; Organ Size; Sex Factors

2009
Polar metabolite of cholesterol induces rat cognitive dysfunctions.
    Neuroscience, 2009, Dec-01, Volume: 164, Issue:2

    Topics: Animals; Apoptosis; Brain; Cholesterol; Cognition Disorders; Eosine Yellowish-(YS); Hematoxylin; Hydroxycholesterols; In Situ Nick-End Labeling; Male; Maze Learning; Memory Disorders; Motor Activity; Neurons; Neuropsychological Tests; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors

2009
Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.
    Journal of Alzheimer's disease : JAD, 2012, Volume: 30, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Brain; Cerebrovascular Disorders; Cognition Disorders; Cohort Studies; Female; Humans; Hydroxycholesterols; Magnetic Resonance Imaging; Male; Retrospective Studies

2012
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
    Neuroscience letters, 2007, Sep-25, Volume: 425, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Biomarkers; Brain; Cholesterol; Cognition Disorders; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Nerve Degeneration; Peptide Fragments; Predictive Value of Tests; tau Proteins

2007